What truly drives hormonal chaos at the molecular level? That’s the enduring question at the heart of the work conducted by endocrine pathophysiologists. Rather than focusing solely on symptoms or organ-level dysfunction, these experts investigate the intricate signaling failures, receptor abnormalities, and transcriptional disruptions that underlie endocrine disorders. From cortisol resistance to rare genetic defects in thyroid hormone synthesis, their lens is tuned to the cellular dialogues that determine health or disease. Their insights are central to refining our understanding of how metabolic, reproductive, and developmental pathways become disrupted—and how targeted therapies can restore physiological balance.
In recent years, endocrine pathophysiologists have contributed significantly to the identification of novel biomarkers and hormone receptor mutations, reshaping diagnostic frameworks for conditions like insulinoma, Cushing’s syndrome, and congenital adrenal hyperplasia. They often collaborate across specialties, supporting translational projects that bridge laboratory discoveries with clinical interventions. Their work also informs the design of hormone replacement therapies, endocrine disruptor risk assessments, and next-generation diagnostics using proteomic and metabolomic profiling. By mapping endocrine dysfunction at its source, they not only advance precision medicine but also help shift treatment paradigms away from symptom control and toward mechanism-based correction—a direction that holds immense promise for endocrinology as a whole.












Title : Changes in the global incidence of diabetes over a quarter century
F Buck Willis, Christian College of Medicine
Title : Beyond glucose: A dual mechanism neuroprotective strategy targeting the GPR146 SIRT1 and ADGRG1 MYC axes in alzheimer’s disease
David Petch, utR Biotech
Title : The prowess of Overripe Banana Sweetener (OBS) in enhancing nutritive values in food and ameliorating glycaemic responses in type 2 diabetes mellitus
Wan Rosli Wan Ishak, Universiti Sains Malaysia
Title : Wound care 2.0 creating a wound care culture TM
David Navazio, Gentell
Title : Beyond the prescription: Using GLP 1 science and lifestyle coaching to prevent prediabetes and support long term blood sugar control
Keith Hersey, Founder/CEO Destroying Diabetes
Title : Fetomaternal outcomes in gestational diabetes mellitus with and without polycystic ovary syndrome
Vinita Singh, AIIMS
Title : Cardiorespiratory fitness inflammatory and neurotrophic biomarkers and cognitive function in early versus longer duration type 2 diabetes mellitus
Arbind Kumar Choudhary, All India Institute of Medical Sciences
Title : Residual Maladaptation Score (RMS): A novel Risk stratification index for early identification of diabetes risk and valvular heart disease in patients with hypothyroidism beyond standard thyroid markers
Ashwin Karuppan V, Gleneagles Hospitals
Title : Biographical disruption mental health and lived experience in adolescents and young adults with type 1 diabetes
Ariela Orbea Cevallos, Universidad Internacional SEK
Title : Enhancing nutrition therapy on diabetics through increased crop productivity
Grace A Asiko, Apiculture Platform of Kenya